🩹 Healing & RecoveryPreclinical

Cartalax

Ala-Glu-Asp-Gly tetrapeptide · Cartilage Bioregulator

A Russian peptide bioregulator studied for cartilage repair and joint health

Typical Dose

5-10 mg daily for 10 days

Route

Subcutaneous

Frequency

Once daily for 10-day course

Cycle

10-day course, 2x per year

Cartalax peptide hero image

Overview

Cartalax is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by the St. Petersburg Institute of Bioregulation and Gerontology. It is part of a family of short regulatory peptides studied for their tissue-specific effects. Cartalax is specifically researched for its effects on cartilage and connective tissue, with studies suggesting it may stimulate chondrocyte proliferation and promote collagen synthesis.

Key Benefits

Cartilage matrix synthesis promotion
Chondrocyte proliferation support
Joint health and mobility
Connective tissue repair
Potential osteoarthritis research applications
Synergistic with BPC-157 for joint recovery

Mechanism of Action

As a peptide bioregulator, Cartalax is thought to penetrate cell nuclei and interact with chromatin, influencing gene expression in a tissue-specific manner. Research suggests it promotes the synthesis of proteoglycans and collagen type II in chondrocytes, the cells responsible for maintaining cartilage matrix.

Dosing Protocol

Typical Dose

5-10 mg daily for 10 days

Dose Range

5-10 mg/day

Frequency

Once daily for 10-day course

Route

Subcutaneous injection

Cycle Length

10-day course, 2x per year

CLINICAL NOTES

Standard bioregulator protocol: 10-day course, repeat every 6 months. Can be combined with BPC-157 for comprehensive joint recovery.

Save to Library

Reconstitution calculator and cycle planner pre-filled with Cartalax defaults

Side Effects & Safety

Generally very well tolerated
Mild injection site reactions
No significant side effects reported in research

IMPORTANT DISCLAIMER

This information is for educational purposes only. Always consult a qualified healthcare provider before starting any peptide protocol. Individual responses vary and medical supervision is recommended.

Research References

Common Stacks

Cartalax is a cartilage-targeting peptide. It pairs well with other joint and connective tissue peptides.

Frequently Asked Questions

Quick Reference

CategoryHealing & Recovery
Research StatusPreclinical
Typical Dose5-10 mg daily for 10 days
RouteSubcutaneous
Cycle10-day course, 2x per year
Opens a print dialog. Choose Save as PDF as the destination to download a clean one-page PDF.

Community Reviews

Real experiences from the Peptide Insights community

Have you used Cartalax?

Real experiences from real people help others make informed decisions. Share what worked, what didn't, and what you wish you'd known before starting.

Dosing insightsResults timelineSide effectsStack combinations
Sign In to Share Your Experience

Free account required. Your review helps the Peptide Insights community.

No reviews yet for Cartalax

Be the first to share your experience. Your insight could help someone else decide if Cartalax is right for them.

Sign In to Be the First
Free Guide

Want to go deeper on Cartalax?

Get our free 32-page Beginner's Guide — plain-language breakdowns of the top peptides, dosing essentials, and safety basics.

Free Beginner's Guide

32-page PDF, instant download

No spam. Unsubscribe anytime.